Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population

International Journal of Geriatric Psychiatry

Volumn 13, Issue 9, 1998, Pages 585-590

  Amar, Khaled ^a   Macgowan, Sian ^b   Wilcock, Gordon ^b   Lewis, Tim ^b   Scott, Margaret ^c  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c BLACKBERRY HILL HOSPITAL   (United Kingdom)

Author keywords

ACE gene polymorphism; ApoE4; CT MRI brain scan; Leukoaraiosis; White matter lesions; White matter low attenuation

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; AMNESIA; ARTICLE; BRAIN INFARCTION; CAREGIVER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIAGNOSTIC IMAGING; DNA POLYMORPHISM; GENE DELETION; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

AGED; APOLIPOPROTEINS E; BRAIN; BRAIN DISEASES; CEREBRAL INFARCTION; GENOTYPE; HUMANS; MEMORY DISORDERS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0031711978     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199809)13:9<585::AID-GPS825>3.0.CO;2-0     Document Type: Article

References (33)

1. Almkvist, O., Wahlund, L. O., Andersson-Lundman, G., Basun, H. and Bäckman, L. (1992) White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neural. 49, 626-632.
2. Amar, K., Bucks, R. S., Lewis, T., Scott, M. and Wilcock, G. K. (1996) The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age & Ageing 25, 443-448.
3. Amar, K., Lewis, T., Wilcock, G. K., Scott, M. and Bucks, R. S. (1995) The relationship between white matter low attenuation on brain CT and vascular risk factors: A memory clinic study. Age & Ageing 24, 411-415.
4. Barley, J., Blackwood, A., Carter, N. D. et al. (1994) Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J. Hypertens. 12, 955-957.
5. Breteler, M. M. B., van Swieten, J. C, Bots, M. L. et al. (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study. Neurology 44, 1246-1252.
6. Cambien, F., Poirier, O., Lecerf, L. et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644.
7. Catto, A., Carter, A. M., Barrett, J. H. et al. (1996) Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 27, 435-440.
8. Czech, C., Förstl, H., Hentschel, F. et al. (1994) Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: Prevalence, plasma cholesterol levels and cerebrovascular change. Eur. Arch. Psychiat. Clin. Neurosci. 243, 291-292.
9. De Reuck, J., Decoo, D., Strijckmans, K. and Lemahieu, I. (1992) Does the severity of leukoaraiosis contribute to senile dementia? Eur. Neural. 32, 199-205.
10. Frisoni, G. B., Geroldi, C., Bianchetti, A. et al. (1994) Apolipoprotein E ε4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 8, 1703.
11. George, A. E., de Leon, M. J., Gentes, C. I. et al. (1986) Leukoencephalopathy in normal and pathologic aging: 1. CT of brian lucencies. AJNR 7, 561-556.
12. Hachinski, C., Illiff, L. D. and Iliff, M. P. (1975) Cerebral blood flow in dementia. Arch. Neural. 32, 632-635.
13. Hachinski, V. C., Potter, P. and Merskey, H. (1987) Leuko-araiosis. Arch. Neural. 44, 21-23.
14. Hofman, A., Ott, A., Breteler, M. et al. (1997) Atherosclerosis, Apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
15. Janota, I., Mirsen, T. R., Hachinski, V. C., Lee, D. H. and Merskey, H. (1989) Neuropathologic correlates of leuko-araiosis. Arch. Neural. 46, 1124-1128.
16. Kosunen, O., Talasniemi, S., Lehtovirta, M. et al. (1995) Relation of coronary atherosclerosis and Apolipoprotein E genotypes in Alzheimer's patients. Stroke 26, 743-748.
17. Kuusisto, J., Koivisto, K., Kervinen, K. et al. (1994) Association of Apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Brit. Med. J. 309, 636-638.
18. Longstreth, W. T., Manolio, T. A., Arnold, A. et al. (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The cardiovascular health study. Stroke 27, 1274-1282.
19. Maeda, Y., Ikeda, Y., Ebata, H. et al. (1996) Angiotensin-converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke. Stroke 27, 1521-1523.
20. Markus, H., S., Barley, J., Lunt, R. et al. (1995) Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 26, 1329-1333.
21. McKhann, G., Drachman, D. A., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
22. Owen, M., Liddell, M. and McGuffin, P. (1994) Alzheimer's Disease. Brit. Med. J. 308, 672-673.
23. Pantoni, L., Garcia, J. H. and Gutierrez, J. A. (1996) Cerebral white matter is highly vulnerable to ischaemia. Stroke 27, 1641-1647.
24. Pirttilä, T., Lehtimäki, T., Rinne, J. et al. (1996) The frequency of Apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neural. Scand. 93, 352-354.
25. Rezek, D. L., Morris, J. C., Fulling, K. H. and Gado, M. H. (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal ageing. Neurology 37, 1365-1368.
26. Rigat, B., Hubert, C., Corval, P. and Soubrier, F. (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene. Nucleic Acids Res. 20, 1433.
27. Schmidt, R., Fazekas, F., Offenbacher, H. et al. (1993) Neuropsychologic correlates of MRI white matter hyperintensities. Neurology 43, 2490-2494.
28. Schmidt, R., Schmidt, H., Fazekas, F. et al. (1997) Apolipoprotein E polymorphism and silent micro-angiopathy-related cerebral damage. Results of the Austrian stroke prevention study. Stroke 28, 951-956.
29. Sharma, P., Carter, N. D., Barley, J. and Brown, M. M. (1994) Molecular approach to assessing the genetic risk of cerebral infarction: Deletion polymorphism of the ACE gene encoding angiotensin 1-converting enzyme. J. Hum. Hypertens. 8, 645-648.
30. Teo, K. K. (1995) Angiotensin converting enzyme genotypes and disease - conflicting results from research leaves the picture unclear. Brit. Med. J. 311, 762-763.
31. Wallin, A., Blennow, K., Uhlemann, C., Langström, G. and Gottfries, C. G. (1989) White matter low attenuation in Alzheimer's disease and vascular dementia -diagnostic and pathogenetic aspects. Acta Neural. Scand. 80, 518-523.
32. Wenham, P. R., Price, W. H. and Blundell, G. (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.
33. Ylikoski, R., Ylikoski, A., Erkinjuntti, T., Sulkava, R., Raininko, R. and Tilvis, R. (1993) White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch. Neural. 50, 818-824.